Cargando…
Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery
BACKGROUND: Various types of markers have been used so far in order to reveal myocardial perfusion defect. However, these markers usually appear in the necrosis phase or in the late stage. Having been the focus of various investigations recently, ischemia-modified albumin (IMA) is helpful in establi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398305/ https://www.ncbi.nlm.nih.gov/pubmed/22221979 http://dx.doi.org/10.1186/1749-8090-7-3 |